Family Communication and Cascade Testing

Because genetic variants are shared among biological relatives, a result in one person frequently has implications for others in the family. Family communication concerns how patients disclose genetic risk to relatives, and cascade testing is the systematic offer of testing to at-risk relatives once a variant is identified in a family. Together they make genetic counseling distinctively familial, raising practical, ethical, and relational challenges around how information travels through a family.

Definition

Family communication of genetic risk is the process by which a patient shares genetic information with biological relatives, and cascade testing (cascade screening) is the systematic identification and testing of at-risk relatives after a disease-causing variant is found in an index case.

Scope

This topic covers how genetic risk information is communicated within families and how cascade testing extends testing to at-risk relatives, including the barriers to disclosure, the role of the index patient, and interventions to support family communication. It is a reference and educational overview, not operational guidance for contacting relatives or conducting a cascade program for a specific family.

Core questions

• How do patients decide whether and how to tell relatives about genetic risk?
• What barriers impede the flow of genetic information within families?
• How is cascade testing organized once a familial variant is identified?
• What is the counselor's role in supporting family communication while respecting privacy?

Key concepts

• Index case (proband)
• Cascade testing of at-risk relatives
• Disclosure of genetic risk
• Barriers to family communication
• Duty to warn versus confidentiality
• Family-mediated versus direct contact of relatives

Mechanisms

Once a pathogenic variant is identified in an index patient, relatives who may share it can be offered targeted testing in a cascade, allowing those who carry the variant to access management and reassuring those who do not. In most settings this depends on the index patient disclosing the information to relatives, so the flow of information is shaped by family relationships, understanding, and willingness to communicate. Systematic reviews show that disclosure is influenced by closeness of the relationship, perceived relevance, and emotional factors, and structured counseling interventions have been developed to help patients communicate with their relatives.

Clinical relevance

Family communication and cascade testing illustrate why genetic results are rarely a purely individual matter and how at-risk relatives can be identified once a familial variant is known. This entry describes the process and its challenges for reference and education; it does not instruct how to contact relatives or run a cascade program for a particular family, and it does not give individual testing advice.

Epidemiology

Cascade testing is used for several inherited conditions in which early identification of carriers enables management, such as familial hypercholesterolemia and inherited cancer susceptibility; uptake among relatives is often incomplete, reflecting barriers in family communication. These observations describe program-level patterns rather than any individual's situation.

Evidence & guidelines

A systematic-review literature documents the determinants and outcomes of family communication, and condition-specific reviews discuss cascade screening and the role of genetic testing; counseling interventions to support disclosure have been evaluated in observational studies. Gaff and colleagues' systematic review and the familial hypercholesterolemia cascade literature are frequently cited references.

History

As gene-specific testing made it possible to identify a familial variant in an index patient, attention turned to reaching at-risk relatives, giving rise to cascade testing programs in conditions such as familial hypercholesterolemia. Research through the 2000s characterized the substantial barriers to family communication, and subsequent work developed and tested counseling interventions to help index patients share genetic information with their relatives.

Debates

Who should be responsible for informing at-risk relatives?

Practice generally relies on the index patient to tell relatives, balancing patient confidentiality against relatives' interest in knowing; whether and when health services should contact relatives directly remains ethically and legally contested.

Key figures

• Clara Gaff
• Angus Clarke
• Carma Bylund
• Joshua Knowles

Seminal works

• gaff-2007
• knowles-2017

Frequently asked questions

What is cascade testing?

Cascade testing is the systematic offer of targeted testing to biological relatives of a person found to carry a disease-causing variant, so that at-risk relatives can learn whether they share it and access appropriate management.

Why is communicating genetic risk to relatives difficult?

Disclosure usually depends on the patient telling relatives and is shaped by family relationships, emotions, and perceived relevance, so information often does not reach everyone who could benefit; counseling interventions aim to support this communication.